Aarti Pharmalabs Limited

About

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalabs Limited was incorporated in 2019 and is headquartered in Mumbai, India.

Key Metrics

as of Sep 2026

Market Cap7,788 Cr

P/E36.20

Div Yield0.41 %

Book Value₹234.00

52w High₹946.00

52w Low₹584.00

Face Value₹5.00

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	535.00	580.00	425.00	417.00	375.00	530.00	471.00	377.00	393.00	415.00	373.00	356.00	358.00
Expenses	398.00	463.00	322.00	343.00	280.00	386.00	356.00	293.00	310.00	307.00	285.00	282.00	281.00
Operating Profit	136.00	117.00	103.00	74.00	95.00	143.00	115.00	85.00	84.00	107.00	88.00	74.00	77.00
OPM %	25.00	20.00	24.00	18.00	25.00	27.00	24.00	22.00	21.00	26.00	24.00	21.00	21.00
Other Income	3.00	11.00	-3.00	3.00	2.00	-3.00	12.00	3.00	2.00	6.00	0.00	0.00	5.00
Depreciation	30.00	28.00	29.00	25.00	23.00	21.00	21.00	19.00	18.00	17.00	17.00	16.00	15.00
Interest	13.00	17.00	13.00	11.00	7.00	6.00	10.00	5.00	4.00	4.00	4.00	4.00	4.00
Profit before tax	96.00	83.00	59.00	42.00	67.00	114.00	96.00	63.00	63.00	91.00	67.00	54.00	62.00
Tax %	26.00	25.00	25.00	26.00	24.00	22.00	24.00	25.00	25.00	31.00	29.00	22.00	23.00
Net Profit	71.00	62.00	44.00	31.00	51.00	89.00	74.00	48.00	47.00	63.00	48.00	42.00	48.00
EPS in Rs	7.86	6.84	4.84	3.41	5.65	9.80	8.11	5.28	5.20	6.95	5.32	4.61	5.26

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Sales	1,798.00	1,771.00	1,502.00	1,511.00	941.00	0.00	0.00
Expenses	1,425.00	1,345.00	1,156.00	1,203.00	761.00	0.00	0.00
Operating Profit	373.00	427.00	346.00	308.00	180.00	0.00	0.00
OPM %	21.00	24.00	23.00	20.00	19.00	—	—
Other Income	13.00	14.00	11.00	1.00	3.00	0.00	0.00
Interest	47.00	26.00	17.00	20.00	11.00	0.00	0.00
Depreciation	104.00	79.00	66.00	56.00	37.00	0.00	0.00
Profit before tax	234.00	336.00	275.00	233.00	134.00	0.00	0.00
Tax %	25.00	23.00	27.00	26.00	20.00	—	0.00
Net Profit	176.00	257.00	201.00	172.00	107.00	0.00	0.00
EPS in Rs	19.44	28.39	22.14	18.95	—	—	—
Dividend Payout %	18.00	18.00	14.00	11.00	0.00	—	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Equity Capital	45.00	45.00	45.00	45.00	0.25	0.25	0.25
Reserves	1,937.00	1,799.00	1,576.00	1,393.00	1,284.00	0.00	0.00
Borrowings	754.00	411.00	272.00	208.00	327.00	0.00	0.00
Other Liabilities	591.00	468.00	404.00	330.00	215.00	0.00	0.00
Total Liabilities	3,328.00	2,724.00	2,297.00	1,976.00	1,827.00	0.00	0.00
Fixed Assets	1,525.00	1,059.00	953.00	848.00	701.00	0.00	0.00
CWIP	305.00	369.00	137.00	102.00	187.00	0.00	0.00
Investments	44.00	57.00	62.00	55.00	40.00	0.00	0.00
Other Assets	1,453.00	1,239.00	1,145.00	971.00	898.00	0.00	0.00
Total Assets	3,328.00	2,724.00	2,297.00	1,976.00	1,827.00	0.00	0.00

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash from Operating Activity	257.00	340.00	184.00	216.00	-65.00	0.00	0.00
Cash from Investing Activity	-425.00	-420.00	-184.00	-116.00	-134.00	0.00	0.00
Cash from Financing Activity	171.00	79.00	4.00	-157.00	255.00	0.00	0.00
Net Cash Flow	3.00	-1.00	4.00	-56.00	56.00	0.00	0.00
Free Cash Flow	-191.00	-93.00	-5.00	99.00	-201.00	0.00	0.00
CFO/OP %	82.00	93.00	67.00	88.00	-28.00	—	100.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Debtor Days	119.00	114.00	109.00	90.00	118.00	—
Inventory Days	283.00	226.00	283.00	240.00	359.00	—
Days Payable	144.00	103.00	124.00	95.00	106.00	—
Cash Conversion Cycle	258.00	236.00	268.00	235.00	371.00	—
Working Capital Days	94.00	118.00	135.00	118.00	137.00	—
ROCE %	11.00	17.00	16.00	16.00	18.00	0.00

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	42.86	43.08	43.10	42.88	43.72	44.29	44.65	46.10	46.46	46.46	46.46	46.30
FIIs	8.17	8.39	7.69	8.02	7.34	7.36	8.64	7.38	7.07	8.33	8.17	8.45
DIIs	7.22	7.40	7.66	6.95	7.80	7.53	10.36	11.35	11.47	9.97	9.91	10.51
Public	41.74	41.10	41.54	42.12	41.12	40.81	36.33	35.17	35.00	35.24	35.45	34.73
No. of Shareholders	176,506	179,373	184,489	190,655	187,039	196,314	185,111	185,436	189,012	204,122	215,796	226,286

Corporate Actions

5 records

Action	Ex Date	Record Date	Ratio	Amount (₹)
Dividend	16 Feb 2026	16 Feb 2026	—	1.50
Dividend	15 Sep 2025	15 Sep 2025	—	2.50
Dividend	14 Feb 2025	14 Feb 2025	—	2.50
Dividend	31 Jul 2024	31 Jul 2024	—	1.00
Dividend	16 Feb 2024	19 Feb 2024	—	2.00